Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus-Reference-Cited by-同舟云学术

Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus

Published:2020-01 Issue:1 Volume:145 Page:173-182
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Silverberg Jonathan I.,Pinter Andreas,Pulka Grazyna,Poulin Yves,Bouaziz Jean-David,Wollenberg Andreas,Murrell Dédée F.,Alexis Andrew,Lindsey Lisa,Ahmad Faiz,Piketty Christophe,Clucas Alan

Funder

Nestlé Skin Health-Galderma R&D

Galderma

GlaxoSmithKline

Abbvie

Amgen

AnaptysBio

Boehringer Ingelheim

Bond Avillion

Celgene

Devonian

Eli Lilly

Janssen

Leo Pharma

Merck Serono

Pfizer

UCB Pharma

Almirall

Beiersdorf

Bioderma

Chugai

Galapagos

Hans Karrer

L'Oreal

Maruho

MedImmune

Novartis

Pierre Fabre

Regeneron

Santen

Sanofi-Aventis

Sanofi

Anacor

Menlo

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference23 articles.

1. Nemolizumab in patients with moderate-to-severe atopic dermatitis: randomized, phase II, long-term extension study;Kabashima;J Allergy Clin Immunol,2018

2. Anti-interleukin-31 receptor A antibody for atopic dermatitis;Ruzicka;N Engl J Med,2017

3. The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-co

4. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer;Jones;Nat Rev Immunol,2018

5. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis;Bilsborough;J Allergy Clin Immunol,2006

Cited by 209 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Emerging Biologics for Atopic Dermatitis;Immunology and Allergy Clinics of North America;2024-09

2. Biologic and Small Molecule Therapy in Atopic Dermatitis;Biomedicines;2024-08-13

3. The role of nemolizumab in the treatment of atopic dermatitis for the adult population;Immunotherapy;2024-08-09

4. Sensory sentinels: Neuroimmune detection and food allergy;Immunological Reviews;2024-08-02

5. Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials;The Lancet;2024-08